Purpose For the quantification of cardiac 123 I-metaiodobenzylguanidine (MIBG) uptake, the mediastinum is commonly used as a reference region reflecting nonspecific background activity. However, variations in the quantity of vascular structures in the mediastinum and the rate of renal clearance of 123 I-MIBG from the blood pool may contribute to increased interindividual variation in uptake. This study examined the relationship between changes in heart (H) and mediastinal (M) counts and the change in vascular 123 I-MIBG activity, including the effect of renal function. Methods Fifty-one subjects with ischemic heart disease underwent early (15 min) and late (4 h) anterior planar images of the chest following injection of 123 I-MIBG. Vascular 123 I-MIBG activity was determined from venous blood samples obtained at 2 min, 15 min, 35 min, and 4 h post-injection. From the vascular clearance curve of each subject, the mean blood counts/min per ml at the time of each acquisition and the slope of the clearance curve were determined. Renal function was expressed as the estimated creatinine clearance (e-CC) and the estimated glomerular filtration rate (e-GFR). Relations between H and M region of interest (ROI) counts/pixel, vascular activity, and renal function were then examined using linear regression. Results Changes in ROI activity ratios between early and late planar images could not be explained by blood activity, the slope of the vascular clearance curves, or estimates of renal function. At most 3% of the variation in image counts could be explained by changes in vascular activity (p= 0.104). The e-CC and e-GFR could at best explain approximately 1.5% of the variation in the slopes of the vascular clearance curve (p=0.194). Conclusion The change in measured H and M counts between early and late planar 123 I-MIBG images is unrelated to intravascular levels of the radiopharmaceutical. This suggests that changes in M counts are primarily due to decrease in soft tissue activity and scatter from the adjacent lungs.
Introduction
The myocardial sympathetic nervous system is activated in patients with heart failure (HF) and this activation has been shown to be associated with increased mortality [1] . Cardiac sympathetic hyperactivity can be scintigraphically visualized by 123 I-metaiodobenzylguanidine (MIBG), a radiolabeled analogue of noradrenalin. This noninvasive technique has been demonstrated to be a powerful prognostic marker in HF patients [2] [3] [4] .
In myocardial 123 I-MIBG imaging, the most commonly used quantitative parameters are the heart to mediastinum (H/M) ratio and washout (WO) determined from planar images. The H/M is a measure of specific to nonspecific uptake, while the WO is a measure of neuronal integrity. A basic assumption associated with use of the mediastinum as a reference for H/M and WO calculations is that the counts in this region represent nonspecific binding of the radioligand.
One potential confounder for assessment of nonspecific 123 I-MIBG background activity is residual tracer in the blood. Since the mediastinum contains a relatively large volume of vascular structures, intravascular 123 I-MIBG activity may contribute to total mediastinal activity which may influence the quantification of the H/M ratio. Since the clearance rate of 123 I-MIBG from the blood is largely dependent on renal function [5, 6] , and renal dysfunction is often present in HF patients, differences in the rate of vascular clearance may also contribute to increased interindividual variation in uptake quantification [7, 8] .
The objective of this study was to assess the magnitude of the influence of residual vascular 123 I-MIBG activity on image quantification by examining the relationship between changes in vascular activity and changes in heart (H) and mediastinal (M) activity between early and late planar 123 I-MIBG images.
Materials and methods
As part of a prospective multicenter trial [9] , 51 subjects (48 male, 3 female; mean age 65.2) with ischemic heart disease (history of ≥ 1 myocardial infarction) underwent myocardial 123 I-MIBG imaging. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by each institution's human research committee. All subjects signed informed consent before performance of any study procedure.
Imaging procedures
All subjects received 370 MBq (10 mCi;±10%) of 123 I-MIBG (AdreView™, GE Healthcare) and underwent 10-min planar images of the anterior thorax at 15 min (early; e) and 4 h (late; l) post-injection (p.i.). The images were acquired with a 20% energy window centered at 159 keV, low-energy high-resolution (LEHR) collimation, and stored in a 128× 128 matrix. All digital image files were sent to an Imaging Core Laboratory (ICL) for evaluation and analysis.
Image analysis
An experienced nuclear medicine technologist processed all the planar images to determine the H and M count densities. The heart region of interest (ROI) was drawn manually to include both ventricles and any atrial activity that was clearly visible. A 7×7 pixel square mediastinal ROI was drawn in the upper mediastinum, using the apices of the lungs as anatomic landmarks (Fig. 1) . Activity per ROI (mean counts/pixel) was corrected for decay to the time of injection and expressed as activity in the myocardium and mediastinum at 15 min and 4 h p.i. (H e , H l , H l /H e , M e , M l , and M l /M e ). In addition, commonly used semiquantitative 123 I-MIBG myocardial parameters were assessed to better describe the clinical condition of the subjects. Early (15 min p.i.) and late (4 h p.i.) H/M ratios were calculated as the ratios of the mean counts per pixel in the two ROIs. All images and ROIs were reviewed by three independent readers, and a single aggregate H/M was derived for each image, either the value accepted by at least two readers, or if this criterion was not satisfied, the average H/M for all readers [9] . In addition, myocardial WO was calculated as:
Vascular activity
Blood samples (2 ml) were taken at 2 min, 15 min, 35 min, and 4 h p.i. Subsequently, 1-ml aliquots were counted in a well counter (energy peak at 159 keV with a 15% energy window). Activity (counts/min) was corrected for decay to the time of injection. For each patient a vascular clearance curve was plotted. Figure 2 shows a typical example with 
In this typical example of a blood activity clearance curve, there is a clear distinction between a more accelerated phase and a slower phase. The slopes of both the faster (S f ) and slower (S s ) phases were calculated as illustrated in the figure two distinct phases, an accelerated clearance followed by a slower clearance. The slopes of the two phases of the clearance curves were determined according to biexponential curve fitting [accelerated phase (S f ) and the slower phase (S s ), expressed as cpm/ml per min]. Based upon the vascular clearance curve, the mean activity (cpm/ml) was calculated for the time intervals during which the two planar images were acquired (15-25 min and 3 h 50 min-4 h p.i.: V e and V l ). The ratio of V e and V l and the ratio between the slopes of the accelerated phase (S f ) and the slower phase (S s ) of the blood clearance were then calculated.
Determination of renal function
Serum concentrations of creatinine were determined from blood samples obtained as part of screening evaluations performed within 7 days prior to 123 I-MIBG imaging. Analyses were performed at a central laboratory, with reference ranges of 75-111 μmol/l for men and 53-106 μmol/l for women.
Renal function was estimated using two methods. Estimated creatinine clearance (e-CC) was calculated (in ml/min) using the Cockcroft-Gault equation [10] : 
Results
Demographic and cardiac medical history information for the 51 subjects included in the study is summarized in Table 1 . The majority of patients was male, had New York Heart Association (NYHA) class II HF, and had left ventricular ejection fraction (LVEF) < 40%. Eight patients had no history of HF. The majority of subjects were on a combination of beta-adrenergic receptor blockers and angiotensin-converting enzyme (ACE) Table 1) .
Estimates of renal function showed a substantial variation (Table 1 ). In 26 (51%) patients creatinine levels were above the normal limit (25 men and 1 woman). Calculated e-CC was < 60 ml/min in 19 (38%) patients and the calculated e-GFR was < 60 ml/min per 1.73 m 2 in 24 (47%) patients.
There was a considerable range in the initial (i.e., fast) part of the 123 I-MIBG vascular clearance curves (Fig. 3 ). Despite this individual variation, the mean S f was more than 60 times steeper compared to the mean S s (Table 2) . Mean intravascular activity (cpm/ml) decreased approximately 65% between 15 min and 4 h p.i. (Table 3 ). The mean scintigraphically determined myocardial and mediastinal activity (counts/min) decreased approximately 37 and 33%, respectively, between 15 min and 4 h p.i. (Table 3) .
Variation in any of the scintigraphic parameters (M e , M l , M l /M e , H e , H l , and H l /H e ) could not be explained by intravascular activity (Table 4) . At most the counts in the blood at 15 min (V e ) could explain approximately 3% of the variation in the mediastinal counts at 15 min (M e ) (p= 0.120). Variation of the scintigraphic parameters could also not be explained by the slope of the clearance curves ( Table 5 ). The slope of the clearance curves could at best explain up to 3% of the variation in the mediastinal counts (M e vs S f and M l vs S s , p=0.105 and p=0.100, respectively).
The variability in the change of intravascular activity (S f , S s , and S f /S s ) could not be explained by either estimate of renal function (e-CC or e-GFR) ( Table 6 ). The e-CC could at best explain approximately 1.5% of the variation in the fast slope of the vascular clearance curve (e-CC vs S f , p=0.194).
Discussion
Most in vivo scintigraphic quantification of regional neurotransporter activity or receptor density involves comparison of uptake in a target ROI to that in a reference region of nonspecific uptake/binding. For assessment of sympathetic myocardial activity with 123 I-MIBG scintigraphy, use of the mediastinum as a reference region is based on the assumption that there is a negligible amount of specific uptake of 123 I-MIBG in this region. In addition, presence of 123 I-MIBG in the blood pool is also assumed to be insignificant. The present results demonstrate that changes in blood pool/vascular 123 I-MIBG activity do not significantly correlate with changes in heart and mediastinum activity between early and late planar images. This is I-MIBG from the blood and uptake into organs (such as the heart) by means of the norepinephrine transporter.
As intravascular activity appears to play no role in the variation of the counts measured in the mediastinum, those counts likely reflect a combination of mediastinal tissue activity and scatter from 123 I-MIBG in adjacent organs (e.g., liver, lungs) [13] . This shows that for routine quantification, the mediastinum is acceptable as a reference region. However, these findings do not confirm that the mediastinum represents a background region with only nonspecific uptake/binding. To test this hypothesis would require a study where the specific uptake of 123 I-MIBG via the presynaptic norepinephrine transporter (i.e., uptake 1) was blocked and compared to a similar study without blocking. To our knowledge this type of study has not been performed in humans.
In subjects with normal renal function, intravenously administered 123 I-MIBG is almost exclusively excreted via the kidneys within 24 h after injection, with approximately 35% of administered 123 I-MIBG already excreted by 6 h [5, 6] . There are complex interactions between sympathetic regulation of renal function and cardiac function. For example, increased sympathetic activity reduces the filtration fraction [14, 15] . In addition, renal dysfunction is often present in HF patients, which may further increase the interindividual variation of blood pool clearance [7, 8] . Moreover, as a reduced GFR is associated with a reduced blood clearance of 123 I-MIBG, the excretion of 123 I-MIBG is not only dependent on filtration but also by tubular secretion [16] . In the present study, although approximately 40% of the patients had decreased renal function, differences in the rate of renal excretion did not contribute to variability in the mediastinal and myocardial I-MIBG in humans is very stable and not subject to in vivo deiodination [17] . In addition, the clearance rate of both 123 I-MIBG and free 123 I from the blood pool is rapid and is almost exclusively dependent on renal excretion. Therefore, the impact of free 123 I on the present results should be negligible.
In conclusion, in patients with ischemic heart disease, due to rapid clearance of 123 I-MIBG from the blood, the heart and mediastinal count densities measured on planar 123 I-MIBG images at 15 min and 4 h are not affected by residual vascular activity. In addition, this observation holds for the broad range of renal function commonly encountered in heart disease patients. Therefore, no correction for blood pool activity or renal function is needed for the calculation of myocardial WO. However, the clinical appropriateness of using mediastinal activity as a background correction in such calculations, which depend on the assumption that there is no specific uptake/binding in this region, remains to be demonstrated.
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